Results 41 to 50 of about 338,185 (301)

Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment

Journal of Environmental and Public Health, 2021
Novel coronavirus first appeared in Wuhan, China, in December 2019, and it speedily expanded globally. Some medications which are used to treat other diseases seem to be effective in treating COVID-19 even without explicit support. The existing drugs that are summarized in this review primarily focused on therapeutic agents that possessed activity ...
Zemene Demelash Kifle, Akeberegn Gorems Ayele, Engidaw Fentahun Enyew   +2 more
openaire   +2 more sources

Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets

Frontiers in Endocrinology, 2022
Coronavirus disease 2019 (COVID-19) is a serious epidemic, characterized by potential mutation and can bring about poor vaccine efficiency. It is evidenced that patients with malignancies, including prostate cancer (PC), may be highly vulnerable to the ...
Yu Ye, Ziyan Huang, Manying Chen, Manying Chen, Yongfeng Mo, Yongfeng Mo, Zengnan Mo   +6 more
doaj   +1 more source

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Frontiers in Pharmacology, 2020
Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and
Ying Wang, Yang Zhang, Qian Yu, Kun Zhu
doaj   +1 more source

Repurposing Anti-Cancer Drugs for COVID-19 Treatment.

Drug design, development and therapy, 2020
The novel coronavirus disease 2019 (COVID-19) pandemic has caused catastrophic damage to human life across the globe along with social and financial hardships. According to the Johns Hopkins University Coronavirus Resource Center, more than 41.3 million people worldwide have been infected, and more than 1,133,000 people have died as of October 22, 2020.
Borcherding,Nicholas, Jethava,Yogesh, Vikas,Praveen   +2 more
openaire   +4 more sources

Pharmacist interventions for appropriate COVID-19 antiviral therapy in long-term care facilities: A public health initiative

Antimicrobial Stewardship & Healthcare Epidemiology, 2023
Background: Prescribing errors related to the COVID-19 oral antiviral agent nirmatrelvir-ritonavir have been reported and are primarily due to improper renal dosing and significant drug–drug interactions.
Jenna Preusker, Daniel Schroeder, Scott Bergman, Mark Rupp, Brandon Scott, Trevor Van Schooneveld, Andrew Watkins, Matthew Donahue, Muhammad Salman Ashraf   +8 more
doaj   +1 more source

Can Personalized Therapy Revolutionize COVID-19 Treatment Outcomes - Knowledge, Attitude & Practice Survey

Journal of Rawalpindi Medical College, 2020
Background: COVID-19 shows variability depending on ethnicity and environmental factors therefore one type of drug may not be effective in all the populations. Personalized medicine refers to tailoring the treatment in accordance with individual patients.
Manzoor Khan, Sarwat Jahan, Naila Abrar, Laila Saleem, Rabia Mazhar, Abid Hussain   +5 more
doaj   +1 more source

Point-of-care testing for disasters: needs assessment, strategic planning, and future design. [PDF]

, 2009
Objective evidence-based national surveys serve as a first step in identifying suitable point-of-care device designs, effective test clusters, and environmental operating conditions.
Bangs, Bulut, Cazacu, de la Hoz, Dighe, Diiulio, Ender, Farfel, Gerald J. Kost, Ginocchio, Grandjean, Grondhal, Hiransuthikul, Hurt, Ivers, Kazancioglu, Kost, Kost, Kost, Kost, Kost, Kristin N. Hale, Lam, Louie, Lupisan, Millie, MMWR, Nam K. Tran, Nicole L. Gentile, Nishiura, Pabbaraju, Qadri, Rajendran, Richard F. Louie, Schneider, Shaman, Shaman, Sinigalliano, T. Keith Brock, Tao, Thomas, Tyler K. Kitano, Uckay, Vernon, Vollaard   +44 more
core   +1 more source

Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options

Molecular Therapy: Methods & Clinical Development, 2020
The coronavirus disease 2019 (COVID-19) is a new type of pneumonia caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. COVID-19 is affecting millions of patients, and the infected number keeps increasing.
Boxuan Huang, Rongsong Ling, Yifan Cheng, Jieqi Wen, Yarong Dai, Wenjie Huang, Siyan Zhang, Xifeng Lu, Yifeng Luo, Yi-Zhou Jiang   +9 more
doaj   +1 more source

A mini-review on the current COVID-19 therapeutic strategies [PDF]

Chemical Review and Letters, 2020
The coronavirus outbreak (COVID-19) started in china, on 31 December 2019. COVID-19 is a severe acute respiratory syndrome. Research on COVID-19 treatment strategies for development of an effective drug therapy has attracted worldwide attention recently.
Samira Shafiee, Soodabeh Davaran
doaj   +1 more source

Diagnosis and Treatment of Infectious Enteritis in Adult Ruminants. [PDF]

, 2018
Infectious enteritis in adult ruminants is often a result of 1 or more viral, bacterial, or parasitic pathogens. Diagnosis of etiologic agents causing enteritis is important when considering herd implications and zoonotic potential of some etiologies ...
Chigerwe, Munashe, Heller, Meera C
core   +1 more source